SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

Section 3.20   Certain Payments 56
Section 3.21   Brokers 57
Section 3.22   Exclusivity of Representations and Warranties 57
Article IV REPRESENTATIONS AND WARRANTIES OF THE BUYER
Section 4.1   Organization 58
Section 4.2   Authority 58
Section 4.3   No Conflict; Required Filings and Consents 58
Section 4.4   Financing 59
Section 4.5   Brokers 59
Section 4.6   Buyer's Investigation and Reliance 59
Article V COVENANTS
Section 5.1   Conduct of Business Prior to the Closing 60
Section 5.2   Covenants Regarding Information 64
Section 5.3   Notification of Certain Matters 64
Section 5.4   Employee Matters 65
Section 5.5   Consents and Filings; Further Assurances 67
Section 5.6   Refunds and Remittances 69
Section 5.7   Public Announcements 69
Section 5.8   Bankruptcy Court Filings and Approval 69
Section 5.9   Pernix Marks 71
Section 5.10   Assumed Liabilities; Adequate Assurance of Future Performance 71
Section 5.11   Sale Free and Clear 71
Section 5.12   Product Liability Insurance 72
Section 5.13   Intellectual Property Registrations 72
Section 5.14   Medical Inquiries 72
Section 5.15   Transition Services 72
Section 5.16   Certain Matters Regarding Treximet Sale 73
Section 5.17   Corporate Existence 74
Article VI TAX MATTERS
Section 6.1   Transfer Taxes 74
Section 6.2   Tax Cooperation 74
Section 6.3   Certain Tax Elections 74
Section 6.4   Apportionment of Certain Taxes 74
Section 6.5   Payment of Taxes 75
Article VII CONDITIONS TO CLOSING
Section 7.1   General Conditions 75